Stay updated on Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedMinor version revision from v3.3.1 to v3.3.2; no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedThe Publications section wording was updated to indicate PubMed entries are automatically filled and may not pertain to the study, and the revision tag was updated to v3.3.1.SummaryDifference0.1%

- Check29 days agoChange DetectedThe banner about potential delays due to government funding has been removed from the page. The study details, eligibility criteria, and contact information remain unchanged.SummaryDifference0.4%

- Check43 days agoChange DetectedThe page now displays posted results, including primary and secondary outcomes, and shows the results submission and posting dates.SummaryDifference0.5%

- Check71 days agoChange Detected- Added a prominent operating-status notice due to funding lapse and a current operating status link, plus a reminder about visiting opm.gov for updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check79 days agoChange DetectedUpdate the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.